By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ritter Pharmaceuticals, Inc. 

1801 Century Park East
Suite 1820
Los Angeles  California  90067  U.S.A.
Phone: 310-203-1000 Fax: 310-919-1600


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ritter Pharma Reports Second Quarter 2017 Financial Results And Provides Business Update 8/7/2017 8:05:17 AM
Ritter Pharma Reports Further Analysis From Its Phase IIb/III Trial Results Demonstrating Significant Reductions In Lactose Intolerance Symptoms 8/4/2017 9:13:48 AM
Ritter Pharma Reports First Quarter 2017 Financial Results And Provides Business Updates 5/9/2017 10:21:45 AM
Ritter Pharma Announces Issuance Of New Patents For Its Lactose Intolerance Treatment, RP-G28, And Provides An Update On Its Path Forward Into Phase III 5/3/2017 11:06:16 AM
FDA Digests Ritter Pharma's Phase II Microbiome Data 4/13/2017 12:18:53 PM
Tiny SoCal Pharma Ritter Pharma Hails A Mid-Stage Victory After Changing The Primary Endpoint And Recalculating Data Of Lactose Intolerance Drug 3/29/2017 7:02:13 AM
Ritter Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Business Update 2/27/2017 9:30:42 AM
Ritter Pharmaceuticals, Inc. Announces Collaboration With University of British Columbia To Explore Development Of Microbiome Therapeutics In Environmental Enteropathy 2/14/2017 6:55:23 AM
Ritter Pharmaceuticals, Inc. To Ring Today's Nasdaq Stock Market Closing Bell To Kick-off Lactose Intolerance Awareness Month 1/31/2017 7:14:16 AM
Ritter Pharmaceuticals, Inc. Release: Company Announces Collaboration With University of Nebraska To Explore Development Of Microbiome Therapeutics In Metabolic Syndrome 1/23/2017 10:15:21 AM
123456
//-->